Search…
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Search...
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Home
>
Latest
Lates News
28/09/2025
BYD Auto: BYD's eight car transport ships have all been put into operation, leading China's automotive industry into a new stage of global market.
Latest
2 m ago
Saint Quan Group: plans to raise 2.5 billion yuan to develop the new energy battery material industry.
3 m ago
Hongrun Construction: Wins the bid for a 1.36 billion yuan EPC general contracting project.
3 m ago
According to the AI Express of Every Economy, China Securities released a research report on September 28, giving Huace Film & TV (300133.SZ) a "buy" rating. The reasons for the rating mainly include: 1) income slowdown combined with cost prepositioning, Q2 profitability is under pressure in stages; 2) rich reserves in content supply, combined with continued efforts in incremental business development, there are still highlights in the film and television business; 3) actively layout the AI service chain, the performance of computing power services is expected to accelerate in the future. (Daily Economic News)
4 m ago
Nanjing Pharmaceutical (600713.SH): Guangzhou Pharmaceuticals, a subsidiary of Baiyunshan, plans to acquire 145 million shares of the company
7 m ago
Pianzi Huang: Plan to invest 200 million yuan to participate in the Zhongjin Medical Fund.
See all latest